(Q27027021)

Charles Stiller

series ordinal

2

1 reference

language of work or name

1 reference

July 2013

1 reference

Lancet Oncology Commission

published in

1 reference

volume

14

1 reference

issue

8

1 reference

page(s)

e329-36

1 reference

Histopathology and prognosis of Wilms tumorResults from the first national wilms' tumor study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Ultrastructure of malignant rhabdoid tumor of the kidney. A distinctive renal tumor of children

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Rhabdoid tumor of kidney. A report of 111 cases from the National Wilms' Tumor Study Pathology Center

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Malignant renal tumours incidence and survival in European children (1978–1997): Report from the Automated Childhood Cancer Information System project

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Soft tissue sarcomas in the first year of life

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Soft tissue sarcoma across the age spectrum: a population-based study from the Surveillance Epidemiology and End Results database

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

INI1-deficient tumors: diagnostic features and molecular genetics

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Epidemiology of rhabdoid tumors of early childhood

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Monosomy 22 in rhabdoid or atypical teratoid tumors of the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Genomic analysis using high-density single nucleotide polymorphism-based oligonucleotide arrays and multiplex ligation-dependent probe amplification provides a comprehensive analysis of INI1/SMARCB1 in malignant rhabdoid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Frequent hSNF5/INI1 Germline Mutations in Patients with Rhabdoid Tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Familial posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

High-density single nucleotide polymorphism array analysis in patients with germline deletions of 22q11.2 and malignant rhabdoid tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Expression of SMARCB1 (INI1) mutations in familial schwannomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Nonsense Mutation and Inactivation of SMARCA4 (BRG1) in an Atypical Teratoid/Rhabdoid Tumor Showing Retained SMARCB1 (INI1) Expression

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Loss of the epigenetic tumor suppressor SNF5 leads to cancer without genomic instability.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Absence of oncogenic canonical pathway mutations in aggressive pediatric rhabdoid tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Rhabdoid tumor: gene expression clues to pathogenesis and potential therapeutic targets

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Malignant rhabdoid tumors express stem cell factors, which relate to the expression of EZH2 and Id proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

The tumour suppressor hSNF5/INI1 controls the differentiation potential of malignant rhabdoid cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

The requirement for SNF5/INI1 in adipocyte differentiation highlights new features of malignant rhabdoid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

SWI/SNF mediates polycomb eviction and epigenetic reprogramming of the INK4b-ARF-INK4a locus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G1 arrest associated with induction of p16ink4a and activation of RB.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Genetic ablation of Cyclin D1 abrogates genesis of rhabdoid tumors resulting from Ini1 loss

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

RhoA-dependent regulation of cell migration by the tumor suppressor hSNF5/INI1.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Epigenetic inactivation of the tumor suppressor BIN1 drives proliferation of SNF5-deficient tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Malignant rhabdoid tumor of the pelvis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Malignant soft tissue neoplasms with the histologic features of renal rhabdoid tumors: an ultrastructural and immunohistochemical study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Rhabdoid tumour of the kidney: a clinicopathological study of 22 patients from the International Society of Paediatric Oncology (SIOP) nephroblastoma file

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Rhabdoid tumor of the kidney in the National Wilms' Tumor Study: age at diagnosis as a prognostic factor.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Age, stage, and radiotherapy, but not primary tumor site, affects the outcome of patients with malignant rhabdoid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Extra-renal non-cerebral rhabdoid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Rhabdoid tumors of the liver: rare, aggressive, and poorly responsive to standard cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Treatment of metastatic rhabdoid tumor of the kidney

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Primary extracranial rhabdoid tumors. Clinicopathologic features and response to ifosfamide

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Long-term survival after autologous peripheral blood stem cell transplantation in two patients with malignant rhabdoid tumor of the kidney

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Clinical aspects of the rhabdoid tumor of the kidney: A report of the national wilms' tumor study group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Targeting cyclin D1, a downstream effector of INI1/hSNF5, in rhabdoid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Rhabdoid tumor growth is inhibited by flavopiridol

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Therapeutically targeting cyclin D1 in primary tumors arising from loss of Ini1.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Cell cycle arrest and repression of cyclin D1 transcription by INI1/hSNF5.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Evaluation of the antitumor efficacy, pharmacokinetics, and pharmacodynamics of the histone deacetylase inhibitor depsipeptide in childhood cancer models in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Induction of autophagy in malignant rhabdoid tumor cells by the histone deacetylase inhibitor FK228 through AIF translocation.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Phase I study of decitabine in combination with vorinostat in patients with advanced solid tumors and non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Pediatric phase I trial and pharmacokinetic study of vorinostat: a Children's Oncology Group phase I consortium report

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

The tyrosine kinase c-Abl promotes proliferation and is expressed in atypical teratoid and malignant rhabdoid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Systematic analysis of the antiproliferative effects of novel and standard anticancer agents in rhabdoid tumor cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021

Targeting Aurora Kinase A enhances radiation sensitivity of atypical teratoid rhabdoid tumor cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970088-3

7 January 2021